Ranibizumab for diabetic macular edema difficult to treat with focal/grid laser

Background To evaluate the efficacy of intravitreal injections of ranibizumab in patients with diabetic clinically significant macular edema (CSME), when further focal or grid laser was considered to be unsafe. Methods In this retrospective, interventional case study, intravitreal injections of rani...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Graefe's archive for clinical and experimental ophthalmology 2010-11, Vol.248 (11), p.1553-1557
Hauptverfasser:	Kotsolis, Athanasios I., Tsianta, Elizabeth, Niskopoulou, Maria, Masaoutis, Panagiotis, Baltatzis, Stefanos, Ladas, Ioannis D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Diabetic Retinopathy - diagnosis Diabetic Retinopathy - drug therapy Diabetic Retinopathy - physiopathology Female Fluorescein Angiography Humans Intravitreal Injections Laser Coagulation Macular Edema - diagnosis Macular Edema - drug therapy Macular Edema - physiopathology Male Medicine Medicine & Public Health Middle Aged Ophthalmology Prognosis Ranibizumab Retinal Disorders Retreatment Retrospective Studies Tomography, Optical Coherence Visual Acuity - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!